Breaking News
March 25, 2018 - Antibiotic Aneurysm Risk; Real-World Endovasc Tx; Hospital Performance
March 25, 2018 - Annual eye exam is vital if you have diabetes
March 25, 2018 - Humanigen Completes Enrollment of Phase 1 Clinical Trial of Lenzilumab for Treatment of Chronic Myelomonocytic Leukemia
March 25, 2018 - ENDO 2018 Roundup: New Tx Options for Obesity, Low BMD, Benign Thyroid Disease
March 25, 2018 - The protein that prevents loose teeth
March 24, 2018 - Morning Break: Skip the Finger Exam? Self C-Section; Toxic Toenail Fungus
March 24, 2018 - 3-D simulations reveal synergistic mechanisms of the human heart
March 24, 2018 - Newly designed three-part molecule shows promise to treat breast cancers
March 24, 2018 - Pubertal hormones not responsible for changes in social behavior during adolescence
March 24, 2018 - Waning Vaccine Protection May Be Driving Rise in U.S. Mumps Cases
March 24, 2018 - Folic Acid in Utero Tied to Food Allergy Risk
March 24, 2018 - Trial shows safety of drugs for irregular heartbeat patients undergoing treatment
March 24, 2018 - Penn State psychologists shed light on false memories in older adults
March 24, 2018 - Patients who self-discharge should be viewed more positively, say researchers
March 24, 2018 - Wearable brain scanner enables brain imaging whilst moving
March 24, 2018 - Trump Signs $1.3 Trillion Spending Bill, Averts Shutdown
March 24, 2018 - Two drugs prevent heart problems in breast cancer patients
March 24, 2018 - Research provides better understanding of how some cancer cells resist treatment
March 24, 2018 - Certain nutrients found in food may help reduce symptoms of psychotic illness
March 24, 2018 - AbbVie Announces Positive Topline Results from Second Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids
March 24, 2018 - AHRQ Is in Trouble | Medpage Today
March 24, 2018 - Could a pap test spot more than just cervical cancer?
March 24, 2018 - Men have greater hospital readmission risk following firearm injury, study shows
March 24, 2018 - Pediatric psychologist shares 11 warning signs of childhood depression
March 24, 2018 - OncoBreak: ‘I Was Normal Once’; Ending Cervical Cancer; Mammo Controversy
March 24, 2018 - Gum Disease by the Numbers
March 24, 2018 - Studies show tool can identify individual needs, supports to help youths with autism, intellectual disabilities
March 24, 2018 - Study reveals cause of extreme nausea in pregnancy
March 24, 2018 - New findings highlight need to reconsider cervical cancer screening guidelines
March 24, 2018 - Smartwatch App Might Help Detect A-Fib
March 24, 2018 - TAVR Reasonable for Low-Flow, Low-Gradient Aortic Stenosis
March 24, 2018 - Kids with severe brain injuries may develop ADHD: study
March 24, 2018 - Researchers explore ways to help older adults taper off and stop using sedatives
March 24, 2018 - Back pain being mismanaged globally
March 24, 2018 - Fingerprint test accurately and noninvasively detects heroin, cocaine users
March 24, 2018 - Leading experts to promote cardiovascular health at EuroPrevent 2018
March 24, 2018 - A Role for Rituximab in Lupus?
March 24, 2018 - New osteoarthritis genes discovered
March 24, 2018 - Maternal intake of DHA supplement linked to higher fat-free body mass in children
March 24, 2018 - Royal College of Pathologists‘ bulletin provides summary of Tissue Handling Workshop
March 24, 2018 - Maternal alcohol use early in pregnancy may be risk factor for infant abdominal malformation
March 24, 2018 - Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection
March 24, 2018 - Accelerated WBI Should be the Norm for Most Breast Cancers
March 24, 2018 - Experts seek to standardize treatments for childhood rheumatic diseases
March 24, 2018 - Foil-based measuring chip rapidly detects Legionella
March 24, 2018 - Bariatric surgery linked to positive outcomes in very obese adolescents with type 2 diabetes
March 24, 2018 - Researchers identify chemical responsible for carcinogen formation in recycled wastewater
March 24, 2018 - Obesity and severe obesity continue to rise among U.S. adults
March 24, 2018 - Missed hospital appointments increase after spring clock change in the UK
March 24, 2018 - Researchers explore ways to manage and prevent falls in older adults with dementia
March 24, 2018 - Are there risks from secondhand marijuana smoke? Early science says yes.
March 24, 2018 - NUST MISIS researchers produce elastic metal rods for scoliosis treatment
March 24, 2018 - New University of Bath project seeks to make injections safer
March 24, 2018 - Higher-dose RT does not improve survival but reduces recurrence risk for prostate cancer patients
March 24, 2018 - Researchers examine link between knee pain and depression in older adults
March 24, 2018 - FDA Alert: BD Vacutainer Blood Collection Tubes by Becton, Dickinson and Company (BD): Class I Recall
March 24, 2018 - Daytime Sleepiness Linked to Amyloid Accumulation Without Dementia
March 24, 2018 - Energy storehouses in the brain may be source of Alzheimer’s, targets of new therapy
March 24, 2018 - Praising people with autism shows promise for producing more exercise
March 24, 2018 - Using harmless red or infrared light to diagnose breast cancer
March 24, 2018 - Clash over abortion hobbles a health bill. Again. Here’s how.
March 23, 2018 - Virtual nature environment could be new way to recover from stress
March 23, 2018 - New study identifies key cellular mechanisms behind vascular aging in mice
March 23, 2018 - Nightmares Common Among U.S. Troops, But Seldom Reported
March 23, 2018 - Another Record Low for Tuberculosis in U.S.
March 23, 2018 - Changes in the eye connected to a decline in memory
March 23, 2018 - Radiologist creates dramatic teaching tool using power of VR
March 23, 2018 - Grilled meat could be raising the risk of hypertension finds study
March 23, 2018 - Mutations found in bassoon gene may help explain cause of rare brain disorder
March 23, 2018 - Childhood Brain Injuries May be Linked to ADHD Years Later
March 23, 2018 - Why treating addiction with medication should be carefully considered
March 23, 2018 - Researchers make key discovery about cellular pathway linked to myriad of diseases
March 23, 2018 - Researchers uncover cause of rare childhood neurodegenerative disease
March 23, 2018 - Measles infection in early childhood could contribute to later COPD
March 23, 2018 - Opioid painkiller is top prescription in 11 states
March 23, 2018 - Sienna Biopharmaceuticals Announces First Patient Dosed In Proof-of-Concept Trial of Topical By Design™ JAK Inhibitor SNA-125 for Atopic Dermatitis
March 23, 2018 - In Teen Girls, Neural Patterns May Drive Emotional Resilience
March 23, 2018 - Gene-based test for urine detects, monitors bladder cancer
March 23, 2018 - BD to introduce new digital solution for IV chemotherapy administration process at EAHP 2018
March 23, 2018 - New computational method helps to identify tumor cell mutations with greater accuracy
Gene enhancing method is helping discover attainable new drug goals for KRAS-driven cancers

Gene enhancing method is helping discover attainable new drug goals for KRAS-driven cancers

image_pdfDownload PDFimage_print

Cancers pushed by means of mutations within the KRAS gene are a few of the most threatening. For many years, researchers have attempted unsuccessfully to without delay goal mutant KRAS proteins as a method to regard tumors. As an alternative of focused on mutant KRAS itself, researchers at College of California San Diego College of Drugs are actually in search of different genes or molecules that, when inhibited, kill most cancers cells best when KRAS could also be mutated.

The workforce used the CRISPR-Cas9 gene enhancing method to systematically inactivate each gene within the genome of human colorectal most cancers cells with and with out mutant KRAS. They discovered that expansion of KRAS-mutant colorectal most cancers cells in mice used to be lowered by means of roughly 50 % when two genes that encode metabolic enzymes — NADK and KHK — have been additionally inactivated.

The learn about, revealed September 27 in Most cancers Analysis, supplies attainable new drug goals for KRAS-driven cancers.

“We didn’t get those identical effects with most cancers cells grown within the lab — the expansion inhibition we noticed when the NADK and KHK genes have been inactivated best happens in tumors in a mammalian gadget, in a extra real looking microenvironment the place the tumor has to live to tell the tale,” mentioned senior writer Tariq Rana, PhD, professor of pediatrics at UC San Diego College of Drugs and Moores Most cancers Heart. “That means that the metabolic dependencies of tumor cells rising in a laboratory dish might fluctuate dramatically in comparison to the similar cells rising in a dwelling gadget, underscoring attainable boundaries of usual laboratory-based most cancers mobile expansion exams.”

Roughly 20 to 30 % of all human cancers have mutations within the KRAS gene. KRAS mutations happen in most of the maximum deadly and maximum tough to regard cancers, together with lung, pancreatic and colorectal most cancers. KRAS mutant most cancers cells are ready to rewire their metabolism in some way that provides them a expansion benefit in comparison to customary cells.

Rana’s option to treating KRAS-driven cancers — inhibiting different genes or molecules along with KRAS — is named “artificial lethality” since the intervention is best deadly to the mutated cells. In a prior learn about, Rana’s workforce used a library of microRNAs, small items of genetic subject matter, to systematically block protein manufacturing and search for the ones inhibitions which can be artificial deadly together with KRAS mutations.

Of their newest learn about, Rana’s workforce used CRISPR-Cas9 to systematically inactivate genes in two human colorectal most cancers mobile traces — one with customary KRAS and one with a mutant KRAS. They then examined the power of each and every of those mobile traces to develop as tumors in mice. They discovered that inactivating two metabolic enzymes, NADK and KHK, lowered the expansion of KRAS-mutant tumors by means of roughly 50 %, however had no impact on customary KRAS tumors. Additionally they blocked those identical enzymes with commercially to be had small molecule inhibitors and noticed vital relief in tumor expansion in mice best in tumor cells with mutant KRAS.

Rana and workforce additionally known a number of new genes that, when inactivated, had the other impact — they higher KRAS-mutant tumor expansion, however now not the expansion of ordinary KRAS tumors. All these genes are referred to as “tumor suppressors” as a result of they typically stay most cancers mobile expansion in test.

“Some of the sudden findings from our learn about is how acting this sort of genetic display screen without delay in a mammalian microenvironment published now not best new artificial deadly interactions, but additionally new tumor suppressor genes which can be depending on KRAS mutations,” mentioned first writer Edwin Yau, MD, PhD, a hematology/oncology and Most cancers Therapeutics Coaching Program fellow in Rana’s lab.

The sort of new tumor suppressor genes encodes INO80C, a big multi-subunit protein that, amongst different issues, stabilizes the genome. Rana, Yau and co-workers are actually taking steps to hold their findings ahead, with without equal objective of higher working out how KRAS-mutant cancers expand and translating those insights into creating new remedies to prevent them.



Tagged with:

About author

Related Articles